|
End-of-day quote
Shenzhen S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 16.66 CNY | -2.80% |
|
-0.60% | -11.24% |
Company Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 11,197 | 8,633 | 7,574 | 8,470 | 8,523 | 7,565 | - | - |
| Change | - | -22.9% | -12.26% | 11.83% | 0.62% | -11.24% | - | - |
| Enterprise Value (EV) 1 | 11,197 | 9,125 | 8,102 | 9,359 | 9,329 | 8,067 | 7,904 | 7,739 |
| Change | - | -18.5% | -11.21% | 15.51% | -0.31% | -13.53% | -2.03% | -2.08% |
| P/E | 23.5x | 24.9x | 16.8x | 28.1x | 21.3x | 18.3x | 15.1x | 12.2x |
| PBR | 2.41x | 2.06x | 1.7x | 1.91x | 1.85x | 1.54x | 1.44x | 1.23x |
| PEG | - | -0.9x | 0.6x | -0.8x | 0.6x | 5.29x | 0.7x | 0.5x |
| Capitalization / Revenue | 5.58x | 4.14x | 3.37x | 2.76x | 2.51x | 2.02x | 1.78x | 1.5x |
| EV / Revenue | 5.58x | 4.38x | 3.6x | 3.05x | 2.75x | 2.15x | 1.86x | 1.53x |
| EV / EBITDA | 19.2x | 17.4x | 11.5x | 16.5x | 13.5x | 11.9x | 9.39x | 8.08x |
| EV / EBIT | 22.4x | 21.9x | 14.3x | 25.1x | 19.5x | 15.8x | 12.7x | 10x |
| EV / FCF | - | - | 27.6x | 17x | 76.7x | 12.7x | 10.4x | - |
| FCF Yield | - | - | 3.62% | 5.88% | 1.3% | 7.85% | 9.62% | - |
| Dividend per Share 2 | 0.35 | 0.3 | 0.4 | 0.3 | 0.4 | 0.3433 | 0.4925 | 0.495 |
| Rate of return | 1.45% | 1.61% | 2.44% | 1.63% | 2.13% | 2.06% | 2.96% | 2.97% |
| EPS 2 | 1.026 | 0.7488 | 0.9772 | 0.6533 | 0.8815 | 0.912 | 1.102 | 1.365 |
| Distribution rate | 34.1% | 40.1% | 40.9% | 45.9% | 45.4% | 37.6% | 44.7% | 36.3% |
| Net sales 1 | 2,007 | 2,084 | 2,249 | 3,070 | 3,398 | 3,746 | 4,252 | 5,047 |
| EBITDA 1 | 583.7 | 524.7 | 704.2 | 568 | 692.3 | 677.4 | 841.9 | 957.9 |
| EBIT 1 | 499.4 | 416.6 | 565.2 | 373.2 | 479.6 | 511.6 | 620.9 | 774.2 |
| Net income 1 | 412.8 | 346.7 | 452.9 | 300.7 | 400.5 | 423.7 | 512.2 | 634.9 |
| Net Debt 1 | - | 492.3 | 527.8 | 888.3 | 806.5 | 502.6 | 338.8 | 174.5 |
| Reference price 2 | 24.12 | 18.61 | 16.39 | 18.37 | 18.77 | 16.66 | 16.66 | 16.66 |
| Nbr of stocks (in thousands) | 464,207 | 463,881 | 462,139 | 461,094 | 454,067 | 454,067 | - | - |
| Announcement Date | 3/25/22 | 3/31/23 | 3/29/24 | 4/2/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 18.27x | 2.15x | 11.91x | 2.06% | 1.13B | ||
| 12.66x | 3.95x | 9.39x | 2.98% | 29.36B | ||
| 161.67x | 2.76x | 13.95x | -.--% | 11.15B | ||
| 12.83x | 1.08x | 4.49x | 2.66% | 3.71B | ||
| 14.72x | 1.72x | 8.41x | 0.57% | 2.9B | ||
| 34.94x | 3.91x | 14.03x | -.--% | 1.9B | ||
| 51.1x | - | - | 0.7% | 1.85B | ||
| 11.19x | 1.24x | 7.52x | 1.39% | 1.4B | ||
| 33.2x | - | - | 0.45% | 1.01B | ||
| 15.08x | 1.15x | 5.49x | 1.31% | 1B | ||
| Average | 36.57x | 2.25x | 9.40x | 1.21% | 5.54B | |
| Weighted average by Cap. | 45.31x | 3.21x | 10.05x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 300119 Stock
- Valuation Tianjin Ringpu Bio-Technology Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
















